| [1] |
Wang Kun, Zhou Zhongxin, Zang Qiwei.
Predictive value of serum TGF-β1 and VEGF levels in patients with non-small cell lung cancer after single-port thoracoscopic radical resection
[J]. Journal of International Oncology, 2024, 51(4): 198-203.
|
| [2] |
Jiang Xi, Wu Yongcun, Liang Yan, Chu Li, Duan Yingxin, Wang Lijun, Huo Junjie.
Impact of pembrolizumab combined with chemotherapy on angiogenesis and circulating endothelial cells in patients with advanced non-small cell lung cancer
[J]. Journal of International Oncology, 2024, 51(2): 89-94.
|
| [3] |
Chen Peiyao, Jia Junmei.
Mechanism and application of hypoxia affecting immunotherapy drug resistance
[J]. Journal of International Oncology, 2021, 48(8): 489-493.
|
| [4] |
Wang Miao, Liu Peijun.
Expression and clinical significance of HIF-1α and OPN in esophageal cancer tissues
[J]. Journal of International Oncology, 2019, 46(8): 466-470.
|
| [5] |
Liu Yanfeng, Guo Hui, Sun Xiyan.
Effects of calcium levofolinate and 5-fluorouracil combined with epirubicin on stress response and VEGF level in patients with gastric cancer
[J]. Journal of International Oncology, 2019, 46(8): 475-479.
|
| [6] |
Li Zhengmin, Zhang Yuming, Zhang Zhen, Zhang Ru, Zhu Jing, Wang Jun.
Mitochondrial energy metabolism mediated via HIF-1 involves the proliferation and apoptosis of renal clear cell carcinoma cells regulated by propofol
[J]. Journal of International Oncology, 2019, 46(12): 711-717.
|
| [7] |
JIANG Run-Mei, TIAN Zhi, LIAO Jiang-Tao, ZENG Juan-Li.
Expressions and clinical significances of Eag1 and VEGF in colorectal cancer tissues
[J]. Journal of International Oncology, 2018, 45(2): 80-86.
|
| [8] |
Nie Xuerong, Dong Liangliang, Zhang Liangming.
Changes of serum levels of VEGF, Arg-1 and iNOS in NSCLC patients before and after microwave ablation and their correlations
[J]. Journal of International Oncology, 2017, 44(8): 569-572.
|
| [9] |
Zhang Junqing, Wang Juncheng, Zhang Gaiying, Chen Jing, Wu Tieying.
Clinical observation of intrapleural hyperthermic perfusion chemotherapy for patients with malignant pleural effusion caused by lung cancer
[J]. Journal of International Oncology, 2017, 44(8): 578-582.
|
| [10] |
Sun Fei, Wang Jianlin, Yu Jingping.
Research advances of cancer therapy targeting HIF-1α-VEGF-VEGFR-2 signaling pathway for malignant tumors
[J]. Journal of International Oncology, 2017, 44(6): 456-.
|
| [11] |
LI Mao-Ji, JIANG Lei, GUAN Quan-Lin.
Efficacy of VEGF and VEGFR pathway inhibitors in the treatment of advanced gastric cancer
[J]. Journal of International Oncology, 2017, 44(5): 393-396.
|
| [12] |
Yu Lan, Zhang Xiaotao, Liu Li, Han Xiaona.
Application of bevacizumab for malignant brain edema
[J]. Journal of International Oncology, 2017, 44(1): 41-44.
|
| [13] |
LI Chun-Pu, WANG Jing, LIU Yan, WANG Ling, LI Ban-Ban, ZHANG Kai-Gang, GUO Dong-Mei.
Inhibition of RPMI8226 myeloma cell xenografted tumor angiogenesis by downregulation of Notch1
[J]. Journal of International Oncology, 2015, 42(8): 661-.
|
| [14] |
Li Zhihan, Zhang Xiliang, Wang Wei.
Expressions and clinical significances of microRNA-126 and vascular endothelial growth factor in gastric carcinoma
[J]. Journal of International Oncology, 2015, 42(12): 900-902.
|
| [15] |
SUN Shu-Lan, ZHENG Xiao-Xia, WEN Li, SU Jin, HE Yan.
Study on enhanced resist to hypoxic/hypoglycemic condition by IL32β in cervical carcinoma C33A cells
[J]. Journal of International Oncology, 2015, 42(11): 801-804.
|
